Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Daly ME, Simone CB 2nd, Redman MW, Hsieh MH, Hesketh PJ, Hu C, Monjazeb AM, Steuer CE, Ganti AK, Kashani R, Bauman JR, Feliciano JL, Moon J, Ku K, Le-Lindqwister N, Baschnagel AM, Maraboyina S, Sherwood GB, Almquist D, Higgins KA, Gray JE, Bradley JD, Kelly K

Open source

DOI: 10.1016/s0140-6736(26)01655-7
Published: 2026 Sep 6
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01655-7,
  title = {Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.},
  author = {Daly ME and Simone CB 2nd and Redman MW and Hsieh MH and Hesketh PJ and Hu C and Monjazeb AM and Steuer CE and Ganti AK and Kashani R and Bauman JR and Feliciano JL and Moon J and Ku K and Le-Lindqwister N and Baschnagel AM and Maraboyina S and Sherwood GB and Almquist D and Higgins KA and Gray JE and Bradley JD and Kelly K},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01655-7},
  url = {https://doi.org/10.1016/s0140-6736(26)01655-7}
}

RIS

TY  - JOUR
TI  - Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.
AU  - Daly ME
AU  - Simone CB 2nd
AU  - Redman MW
AU  - Hsieh MH
AU  - Hesketh PJ
AU  - Hu C
AU  - Monjazeb AM
AU  - Steuer CE
AU  - Ganti AK
AU  - Kashani R
AU  - Bauman JR
AU  - Feliciano JL
AU  - Moon J
AU  - Ku K
AU  - Le-Lindqwister N
AU  - Baschnagel AM
AU  - Maraboyina S
AU  - Sherwood GB
AU  - Almquist D
AU  - Higgins KA
AU  - Gray JE
AU  - Bradley JD
AU  - Kelly K
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01655-7
UR  - https://doi.org/10.1016/s0140-6736(26)01655-7
ER  -

APA

ME, D., 2nd, S. C., MW, R., MH, H., PJ, H., C, H., AM, M., CE, S., AK, G., R, K., JR, B., JL, F., J, M., K, K., N, L., AM, B., S, M., GB, S., D, A., KA, H., JE, G., JD, B., & K, K. (2026). Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01655-7

Source records

pubmed · retrieved 2026-09-25T12:40:51.343Z